Article
Performance of Idylla™ RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer.
International journal of clinical oncology - 1 Jul 2022
Makutani Yusuke, Sakai Kazuko, Yamada Masahiro, Wada Toshiaki, Chikugo Takaaki, Satou Takao, Iwasa Yoko, Yamamoto Hidekazu, de Velasco Marco A, Nishio Kazuto, Kawamura Junichiro
Abstract excerpt
BACKGROUND: The Biocartis Idylla™ platform is a fully automated, real-time PCR-based diagnostic system. The Idylla™ KRAS and NRAS-BRAF Mutation Tests have been developed for the qualitative detection of mutations in KRAS, NRAS and BRAF genes, facilitating the genomic profiling of patients with colorectal cancer. The aim of the present study was to evaluate clinical performances of these tests in Japan. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
